- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0042453

About Vav Lipids Private Limited
Data last updated:
Vav Lipids Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Vav Life Sciences Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC190024. Its GSTIN is 27AACCV9413F1ZA (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.7 Cr. It is led by directors including Arun Radheshyam Kedia and Sabita Kedia.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 51/B Mittal Court 224 Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.81 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹46 Lakh (net margin -3.1%) and EBITDA of ₹1.57 Cr (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 30% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.75 Cr and satisfied charges of ₹11.47 Cr on record.
Vav Lipids Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0042453). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vav.in.
Recognitions & Rankings of Vav Lipids
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address51/B Mittal Court 224 Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vav Lipids Private Limited
The main business activity of Vav Lipids is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vav Lipids Private Limited FY 2024 filings available
Vav Lipids Private Limited reported revenue of ₹14.81 Cr (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Vav Lipids Private Limited
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 30%. EBITDA fell 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vav Lipids Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.57 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹46 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vav Lipids Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vav Lipids are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vav Lipids Private Limited
Vav Lipids has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Radheshyam Kedia Also directs: Vav Life Sciences Private Limited, Vav Biocos Private Limited | Director | 02 Feb 2009 | 17 Years 8 Months | Current |
| Sabita Kedia Also directs: Vav Life Sciences Private Limited | Director | 02 Feb 2009 | 17 Years 8 Months | Current |
| Hareesh Kumar Tibrewala | Director | 10 May 2024 | 2 Years 5 Months | Current |
| Pranav Arun Kedia Also directs: Vav Biocos Private Limited | Director | 20 Jan 2021 | 5 Years 9 Months | Current |
| Rahul Chadrakant Nandre | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Vav Lipids Private Limited
Vav Lipids Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G S S Pharma Private Limited | ₹14.87 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Whitefield, Karnataka, India |
| Tuttsan Pharma Private Limited | ₹14.87 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Kalol, Gujarat, India |
| Kureasia Pharma Private Limited | ₹14.86 Cr (FY 2024) | •••• | •••• | 56.0% | •••• | New Delhi, Delhi, India |
| B D Pharmaceutical Works Private Limited | ₹14.82 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Kolkata, West Bengal, India |
| Rakesh Healthcare (India) Limited | ₹14.82 Cr (FY 2024) | •••• | •••• | 320.0% | •••• | Kalol, Gujarat, India |
| Vav Lipids Private Limited this company | ₹14.81 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
| BKRS Pharma Private Limited | ₹14.8 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Gurgaon, Haryana, India |
| Sridhara Laboratories Private Limited | ₹14.8 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Hyderabad, Telangana, India |
| Whitefield Chemtech Private Limited | ₹14.79 Cr (FY 2017) | •••• | •••• | 108.0% | •••• | Vadodara, Gujarat, India |
| Adonis Phytoceuticals Private Limited | ₹14.78 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | New Delhi, Delhi, India |
| Resonant Pharmaceuticals Private Limited | ₹14.67 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Navagam, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Vav Lipids by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vav Lipids Private Limited
Vav Lipids Private Limited is audited by SHARP & TANNAN for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHARP & TANNAN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vav Lipids Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vav Lipids Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2024 | Sidbi | ₹93.8 Lakh | Open |
| 25 Oct 2024 | Others | ₹3 Cr | Open |
| 30 Dec 2021 | Sidbi | ₹41 Lakh | Open |
| 07 Jul 2021 | Others | ₹6.4 Cr | Open |
| 01 Dec 2021 | Axis Bank Limited | ₹2.65 Cr | Satisfied |
Total charge records: 8 View all charges
MSME Payment Delays by Vav Lipids Private Limited
Vav Lipids Private Limited has 7 MSME Form 1 returns on record between 2021 and 2023, listing 38 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Mass Weigh Systems Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 7 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Vav Lipids Private Limited
Vav Lipids Private Limited has a workforce of 40 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vav Lipids Private Limited
Vav Lipids Private Limited has 9 board changes on record since 2009: 5 appointments and 4 cessations. The latest: Hareesh Kumar Tibrewala ceased to be Additional Director on 29 Sep 2024.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vav Lipids Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vav Lipids Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vav Lipids Private Limited
Vav Lipids has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCV9413F1ZA | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vav Lipids Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Vav Lipids Private Limited
Frequently Asked Questions about Vav Lipids Private Limited
Vav Lipids is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 2009 (17+ years old) and is registered under CIN U24100MH2009PTC190024.
Vav Lipids reported revenue of ₹14.81 Cr for FY 2024 (down 17% YoY).
Vav Lipids has 5 current directors:
- Arun Radheshyam Kedia - Director
- Sabita Kedia - Director
- Hareesh Kumar Tibrewala - Director
- Pranav Arun Kedia - Director
- Rahul Chadrakant Nandre - Director
Vav Lipids reported a net loss of ₹46 Lakh (net margin -3.1%) and EBITDA of ₹1.57 Cr (EBITDA margin 10.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vav Lipids is 33% over three years and 30% over five years. In the latest year (FY 2024) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vav Lipids is 27AACCV9413F1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vav Lipids is U24100MH2009PTC190024. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vav Lipids was incorporated on 02 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vav Lipids by revenue are G S S Pharma Private Limited, Tuttsan Pharma Private Limited, Kureasia Pharma Private Limited, B D Pharmaceutical Works Private Limited, Rakesh Healthcare (India) Limited and 5 more, all in the Pharma industry (Formulations).
Hareesh Kumar Tibrewala ceased to be Additional Director on 29 Sep 2024. Hareesh Kumar Tibrewala was appointed as Director on 10 May 2024. Pranav Arun Kedia ceased to be Additional Director on 30 Oct 2021. Vav Lipids has 9 board changes on record in total.
Yes, Vav Lipids is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0042453).
Vav Lipids has 7 MSME Form 1 returns on record between 2021 and 2023, listing 38 overdue payments to 14 micro and small suppliers. The latest return was filed on 13 Nov 2023.